|View printer-friendly version|
|June 28, 2005 11:29 a.m.|
|Teva Announces Tentative Approval Of Glimepiride Tablets|
Jerusalem, Israel, June 28, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's ANDA for Glimepiride Tablets, 1 mg, 2 mg and 4 mg. Final approval is anticipated upon patent expiration in October 6, 2005.